Identification of Pax5 target genes in early B cell differentiation

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1719-1728

  Pridans, Clare ^a,b,c   Holmes, Melissa L ^a   Polli, Matthew ^a   Wettenhall, James M ^a   Dakic, Aleksandar ^a   Corcoran, Lynn M ^a   Smyth, Gordon K ^a   Nutt, Stephen L ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TRANSCRIPTION FACTOR PAX5; PAX5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL HOMING; CELL LINE; CELL MIGRATION; DNA MICROARRAY; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENOTYPE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; ANIMAL; CELL LINEAGE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS;

EID: 40349107459     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1719     Document Type: Article

References (61)

1. Singh, H., K. L. Medina, and J. M. Pongubala. 2005. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102: 4949-4953.
2. Nutt, S. L., and B. L. Kee. 2007. The transcriptional regulation of B cell lineage commitment. Immunity 26: 715-725.
3. Busslinger, M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22: 55-79.
4. Nutt, S. L., P. Urbanek, A. Rolink, and M. Busslinger. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11: 476-491.
5. Urbanek, P., Z. Q. Wang, I. Fetka, E. F. Wagner, and M. Busslinger. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79: 901-912.
6. Nutt, S. L., A. M. Morrison, P. Dorfler, A. Rolink, and M. Busslinger. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss-and gain-of-function experiments. EMBO J. 17: 2319-2333.
7. Nutt, S. L., B. Heavey, A. G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556-562.
8. Rolink, A. G., S. L. Nutt, F. Melchers, and M. Busslinger. 1999. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401: 603-606.
9. Schaniel, C., L. Bruno, F. Melchers, and A. G. Rolink. 2002. Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood 99: 472-478.
10. Carotta, S., J. Brady, L. Wu, and S. L. Nutt. 2006. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells. Eur. J. Immunol. 36: 3294-3304.
11. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12: 2662-2672.
12. Fitzsimmons, D., W. Hodsdon, W. Wheat, S. M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10: 2198-2211.
13. Schebesta, M., P. L. Pfeffer, and M. Busslinger. 2002. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17: 473-485.
14. Tian, J., T. Okabe, T. Miyazaki, S. Takeshita, and A. Kudo. 1997. Pax-5 is identical to EBB-1/KLP and binds to the VpreB and λ5 promoters as well as the KI and KII sites upstream of the Jκ genes. Eur. J. Immunol. 27: 750-755.
15. Thevenin, C., S. L. Nutt, and M. Busslinger. 1998. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis. J. Exp. Med. 188: 735-744.
16. Souabni, A., C. Cobaleda, M. Schebesta, and M. Busslinger. 2002. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17: 781-793.
17. Tagoh, H., R. Ingram, N. Wilson, G. Salvagiotto, A. J. Warren, D. Clarke, M. Busslinger, and C. Bonifer. 2006. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J. 25: 1070-1080.
18. Holmes, M. L., S. Carotta, L. M. Corcoran, and S. L. Nutt. 2006. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 20: 933-938.
19. Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24: 269-281.
20. Schebesta, A., S. McManus, G. Salvagiotto, A. Delogu, G. A. Busslinger, and M. Busslinger. 2007. Transcription factor pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity 27: 49-63.
21. Soares, M. B., M. F. Bonaldo, P. Jelene, L. Su, L. Lawton, and A. Efstratiadis. 1994. Construction and characterization of a normalized cDNA library. Proc. Natl. Acad. Sci. USA 91: 9228-9232.
22. Kargul, G. J., D. B. Dudekula, Y. Qian, M. K. Lim, S. A. Jaradat, T. S. Tanaka, M. G. Carter, and M. S. Ko. 2001. Verification and initial annotation of the NIA mouse 15K cDNA clone set. Nat. Genet. 28: 17-18.
23. Smyth, G. K., and T. Speed. 2003. Normalization of cDNA microarray data. Methods 31: 265-273.
24. Smyth, G. K., J. Michaud, and H. S. Scott. 2005. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
25. Smyth, G. K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3: Article3.
26. Nutt, S. L., D. Metcalf, A. D'Amico, M. Polli, and L. Wu. 2005. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201: 221-231.
27. Polli, M., A. Dakic, A. Light, L. Wu, D. M. Tarlinton, and S. L. Nutt. 2005. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 106: 2083-2090.
28. Pulendran, B., M. Karvelas, and G. J. Nossal. 1994. A form of immunologic tolerance through impairment of germinal center development. Proc. Natl. Acad. Sci. USA 91: 2639-2643.
29. Nera, K. P., P. Kohonen, E. Narvi, A. Peippo, L. Mustonen, P. Terho, K. Koskela, J. M. Buerstedde, and O. Lassila. 2006. Loss of Pax5 promotes plasma cell differentiation. Immunity 24: 283-293.
30. Roessler, S., I. Gyory, S. Imhof, M. Spivakov, R. R. Williams, M. Busslinger, A. G. Fisher, and R. Grosschedl. 2007. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol. Cell. Biol. 27: 579-594.
31. Huang, R. P., M. Ozawa, K. Kadomatsu, and T. Muramatsu. 1993. Embigin, a member of the immunoglobulin superfamily expressed in embryonic cells, enhances cell-substratum adhesion. Dev. Biol. 155: 307-314.
32. Kallies, A., J. Hasbold, K. Fairfax, C. Pridans, D. Emslie, B. S. McKenzie, A. M. Lew, L. M. Corcoran, P. D. Hodgkin, D. M. Tarlinton, and S. L. Nutt. 2007. Initiation of plasma cell differentiation is independent of the transcription factor Blimp-1. Immunity 26: 555-566.
33. Cobaleda, C., A. Schebesta, A. Delogu, and M. Busslinger. 2007. Pax5: the guardian of B cell identity and function. Nat. Immunol. 8: 463-470.
34. Hamann, J., C. van Zeventer, A. Bijl, C. Molenaar, K. Tesselaar, and R. A. van Lier. 2000. Molecular cloning and characterization of mouse CD97. Int. Immunol. 12: 439-448.
35. Nielsen, P. J., B. Lorenz, A. M. Muller, R. H. Wenger, F. Brombacher, M. Simon, T. von der Weid, W. J. Langhorne, H. Mossmann, and G. Kohler. 1997. Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood 89: 1058-1067.
36. Itoh, M., K. Ishihara, T. Hiroi, B. O. Lee, H. Maeda, H. Iijima, M. Yanagita, H. Kiyono, and T. Hirano. 1998. Deletion of bone marrow stromal cell antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses. J. Immunol. 161: 3974 -3983.
37. Yamashita, Y., K. Oritani, E. K. Miyoshi, R. Wall, M. Bernfield, and P. W. Kincade. 1999. Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J. Immunol. 162: 5940-5948.
38. Coughlin, J. J., S. L. Stang, N. A. Dower, and J. C. Stone. 2005. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J. Immunol. 175: 7179-7184.
39. Tokoyoda, K., T. Egawa, T. Sugiyama, B. I. Choi, and T. Nagasawa. 2004. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20: 707-718.
40. Manie, S. N., A. R. Beck, A. Astier, S. F. Law, T. Canty, H. Hirai, B. J. Druker, H. Avraham, N. Haghayeghi, M. Sattler, et al. 1997. Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J. Biol. Chem. 272: 4230-4236.
41. Cooper, A. B., C. M. Sawai, E. Sicinska, S. E. Powers, P. Sicinski, M. R. Clark, and I. Aifantis. 2006. A unique function for cyclin D3 in early B cell development. Nat. Immunol. 7: 489-497.
42. Lu, R., K. L. Medina, D. W. Lancki, and H. Singh. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17: 1703-1708.
43. Wikstrom, I., J. Forssell, M. Goncalves, F. Colucci, and D. Holmberg. 2006. E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. J. Immunol. 177: 6723-6729.
44. Kee, B. L. 2005. Id3 induces growth arrest and caspase-2-dependent apoptosis in B lymphocyte progenitors. J. Immunol. 175: 4518-4527.
45. Kee, B. L., R. R. Rivera, and C. Murre. 2001. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2: 242-247.
46. Fuxa, M., J. Skok, A. Souabni, G. Salvagiotto, E. Roldan, and M. Busslinger. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18: 411-422.
47. Ikawa, T., H. Kawamoto, L. Y. Wright, and C. Murre. 2004. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20: 349-360.
48. Berland, R., and H. H. Wortis. 2003. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl. Acad. Sci. USA 100: 13459-13464.
49. Peng, S. L., A. J. Gerth, A. M. Ranger, and L. H. Glimcher. 2001. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14: 13-20.
50. Ichikawa, M., T. Asai, S. Chiba, M. Kurokawa, and S. Ogawa. 2004. Runx1/ AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle 3: 722-724.
51. Gebuhr, T. C., G. I. Kovalev, S. Bultman, V. Godfrey, L. Su, and T. Magnuson. 2003. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J. Exp. Med. 198: 1937-1949.
52. Carotta, S., M. L. Holmes, C. Pridans, and S. L. Nutt. 2006. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation. Cell Cycle 5: 2452-2456.
53. Jones, S. L., and E. J. Brown. 1996. FcγRII-mediated adhesion and phagocytosis induce L-plastin phosphorylation in human neutrophils. J. Biol. Chem. 271: 14623-14630.
54. Liu, L., D. C. Cara, J. Kaur, E. Raharjo, S. C. Mullaly, J. Jongstra-Bilen, J. Jongstra, and P. Kubes. 2005. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J. Exp. Med. 201: 409-418.
55. Lean, J. M., C. J. Jagger, B. Kirstein, K. Fuller, and T. J. Chambers. 2005. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146: 728-735.
56. Muramatsu, T., and T. Miyauchi. 2003. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation, and tumor invasion. Histol. Histopathol. 18: 981-987.
57. Ogata, H., I. Su, K. Miyake, Y. Nagai, S. Akashi, I. Mecklenbrauker, K. Rajewsky, M. Kimoto, and A. Tarakhovsky. 2000. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192: 23-29.
58. Kishimoto, H., K. Hamada, M. Saunders, S. Backman, T. Sasaki, T. Nakano, T. W. Mak, and A. Suzuki. 2003. Physiological functions of Pten in mouse tissues. Cell Struct. Funct. 28: 11-21.
59. Anzelon, A. N., H. Wu, and R. C. Rickert. 2003. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4: 287-294.
60. Kallies, A., and S. L. Nutt. 2007. Terminal differentiation of lymphocytes depends on Blimp-1. Curr. Opin. Immunol. 19: 156-162.
61. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.